id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-P-4585-0003,FDA,FDA-2016-P-4585,"Letter from CDER to Acorda Therapeutics, Inc",Other,Letter(s),2017-01-26T05:00:00Z,2017,1,2017-01-26T05:00:00Z,,2017-01-26T18:10:46Z,,0,0,0900006482491b0d